Home
  • Company
    • About
    • Leadership
    • Careers
  • Pipeline
    • Development Pipeline
    • Targeted Therapeutics
    • Systemic Therapeutics
  • Publications
  • Investors
    • Investor Overview
    • Press Releases
    • Events & Presentations
    • SEC Filings
    • Annual & Quarterly Reports
    • Stock Quote & Chart
    • Historical Price Lookup
    • Analyst Coverage
    • Governance Documents
    • Committee Composition
    • Investor FAQs
    • Investor Email Alerts
    • Investor Relations Contact
  • Contact

Publications

Pharmacokinetic stratification of cytokine profiles during anti-TNF induction treatment in moderate-to-severe ulcerative colitis
February 22, 2022 #Targeted Therapeutics
Tofacitinib tissue exposure correlates with endoscopic outcome
February 16, 2022 #Targeted Therapeutics
Development of a novel drug delivery system to deliver drugs directly to the colonic mucosa
July 7, 2021 #Targeted Therapeutics
Development of a novel drug delivery system for targeted treatment of ulcerative colitis
May 20, 2021 #Targeted Therapeutics
Targeted delivery of tofacitinib citrate to the site of disease to improve efficacy and safety
May 20, 2021 #Targeted Therapeutics
Evaluation of novel lab-in-a-capsule technology for SIBO diagnosis
November 23, 2020 #Gastrointestinal Health
Ingestible capsule has potential to improve diagnostics for GI disease
November 9, 2020 #Gastrointestinal Health
Revolutionary GI diagnostics and therapeutics are on the horizon
October 28, 2019 #Gastrointestinal Health
Proof-of-concept data on new ingestible technologies
May 17, 2019 #Gastrointestinal Health

Connect with us

  • Company

    About Leadership Careers

    Pipeline

    Development Pipeline Targeted Therapeutics Systemic Therapeutics
  • Publications

    Targeted Therapeutics Gastrointestinal Health

    Investors

    Investor Overview Press Releases Events & Presentations Annual & Quarterly Reports
  • Connect with Us

    Contact Us
Privacy & Terms of Use

© 2022 Biora Therapeutics, Inc. All rights reserved. Biora Therapeutics is a trademark of Biora Therapeutics, Inc.

Precaution: investigational drug/device combination products. Currently limited by Federal law to investigational use only. Not for sale in the U.S.